Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer

Abstract

BackgroundBreast cancer is one of the leading cause of cancer-related deaths in women worldwide and increasing rapidly in developing countries. In the present study, we investigated the potential role and association of HSP70-2 with breast cancer.MethodsHSP70-2 expression was examined in 154 tumor and 103 adjacent non-cancerous tissue (ANCT) specimens and breast cancer cell lines (MCF7, BT-474, SK-BR-3 and MDA-MB-231) by RT-PCR, quantitative-PCR, immunohistochemistry, Western blotting, flow cytometry and indirect immunofluorescence. Plasmid driven short hairpin RNA approach was employed to validate the role of HSP70-2 in cellular proliferation, senescence, migration, invasion and tumor growth. Further, we studied the effect of HSP70-2 protein ablation on signaling cascades involved in apoptosis, cell cycle and Epithelial-Mesenchymal-Transition both in culture as well as in-vivo human breast xenograft mouse model.ResultsHSP70-2 expression was detected in majority of breast cancer patients (83 %) irrespective of various histotypes, stages and grades. HSP70-2 expression was also observed in all breast cancer cells (BT-474, MCF7, MDA-MB-231 and SK-BR-3) used in this study. Depletion of HSP70-2 in MDA-MB-231 and MCF7 cells resulted in a significant reduction in cellular growth, motility, onset of apoptosis, senescence, cell cycle arrest as well as reduction of tumor growth in the xenograft model. At molecular level, down-regulation of HSP70-2 resulted in reduced expression of cyclins, cyclin dependent kinases, anti-apoptotic molecules and mesenchymal markers and enhanced expression of CDK inhibitors, caspases, pro-apoptotic molecules and epithelial markers.ConclusionsHSP70-2 is over expressed in breast cancer patients and was involved in malignant properties of breast cancer. This suggests HSP70-2 may be potential candidate molecule for development of better breast cancer treatment.Electronic supplementary materialThe online version of this article (doi:10.1186/s13046-016-0425-9) contains supplementary material, which is available to authorized users.

Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy

“…Recently, it has been found that HSP72 (HSP70) plays an essential role in organizing kinetochore-associated microtubules for amplified centrosomes, a cancer specific phenotype which, if not stabilized, triggers mitotic catastrophe and apoptosis [53]. In addition, increased levels of HSP70B (HSP70) contribute to breast cancer metastasis through upregulation of mesenchymal markers such as N-cadherin, MMP2, SNAIL, and vimentin [54]. Furthermore, HSC70 overexpression enhances the glioma cell proliferation, migration, and invasion through phosphorylation and activation of FAK, Src, and Pyk2.…”

Heat Shock Proteins in Alzheimer’s Disease: Role and Targeting

“…Hsp70 binds tumour-suppressor proteins, determining unlimited cellular growth and increased resistance to chemotherapy in breast cancer [ 88 , 92 ]. On the contrary, downregulation of Hsp70 levels in some types of cancers induces differentiation and cell death [ 93 ]. Hsp70 can trigger the activation of the immune response by stimulating both innate and adaptive immunities.…”

Sorefenib inhibits the expressions of heat shock protein70 gene on multiple myeloma (RPMI-8226) and plasma cell leukemia (ARH-77) cell lines

“…Also, HSP70 and HSP90 participate in many key processes in oncogenesis such as self-sufficiency in growth signals, stabilization of mutant proteins, angiogenesis, and metastasis. They act like antiapoptotic chaperones (23,24,25). In our study, HSP70 and HSP90 gene expressions were studied in MM cells and PCL cell lines.…”